This was a year that tested the resilience of the Huntington’s disease (HD) community, with 2025 being remembered for landmark highs followed by disappointing lows shadowed in confusion. Data from clinical trials produced the strongest…
This was a year that tested the resilience of the Huntington’s disease (HD) community, with 2025 being remembered for landmark highs followed by disappointing lows shadowed in confusion. Data from clinical trials produced the strongest…